Vice President, Asset Strategy Lead

Role: Vice President, Asset Strategy Lead for a late-stage, approved oncology asset at Syndax, overseeing strategic planning, external engagement, and lifecycle management. Responsibilities include leading cross-functional asset teams, developing differentiated external strategies (e.g., investigator-sponsored research, scientific outreach), building key academic and investigator relationships, representing the program externally, and aligning clinical, regulatory, and commercial priorities. The role involves long-term planning, risk mitigation, and partnership with senior leadership to optimize asset value and support expansion. Qualifications: Advanced degree in life sciences, medicine, or business (e.g., PhD, MD, MBA); 10+ years in late-stage oncology development, including experience with approved assets and Phase 3 programs; proven strategic leadership, cross-functional collaboration, and external scientific influence experience. High-value specifics: Oncology, late-stage (Phase 3 and post-approval), scientific and commercial integration, investigator-sponsored research, external stakeholder engagement, and portfolio management. Work setup: Based in New York, NY, with a salary range of $380K–$420K; roles may involve external engagement and strategic travel.